These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 6288441
1. Storage of the complement components C4, C3, and C 3-activator in the human liver as PAS-negative globular hyaline bodies. Storch W, Riedel H, Trautmann B, Justus J, Hiemann D. Exp Pathol; 1982; 21(3):199-203. PubMed ID: 6288441 [Abstract] [Full Text] [Related]
3. Immunohistological investigations of PAS-negative globular intracisternal hyalin in human liver biopsy specimens. Storch W. Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(2):155-65. PubMed ID: 2859688 [Abstract] [Full Text] [Related]
4. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase. Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J. J Exp Med; 1981 Jul 01; 154(1):1-12. PubMed ID: 7019379 [Abstract] [Full Text] [Related]
5. The proteolytic activation systems of complement. Reid KB, Porter RR. Annu Rev Biochem; 1981 Jul 01; 50():433-64. PubMed ID: 7023363 [No Abstract] [Full Text] [Related]
9. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF. J Immunol; 1982 Jul 01; 129(1):184-9. PubMed ID: 6211481 [No Abstract] [Full Text] [Related]
10. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B. Volanakis JE. Year Immunol; 1989 Jul 01; 4():218-30. PubMed ID: 2648703 [No Abstract] [Full Text] [Related]
12. Serum complement components in patients with trachoma. Sen DK, Sarin GS, Hiranandani M, Baveja UK. Br J Ophthalmol; 1985 Sep 01; 69(9):707-10. PubMed ID: 3876110 [Abstract] [Full Text] [Related]
13. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ, Ramsey J, Hammer CH, Frank MM. J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833 [Abstract] [Full Text] [Related]
15. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. Low PJ, Ai R, Ogata RT. J Immunol; 1999 Jun 01; 162(11):6580-8. PubMed ID: 10352274 [Abstract] [Full Text] [Related]
16. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition. Santi P, Joiner KA, Hammer CH, Frank MM, Tosi R. J Immunol; 1987 May 15; 138(10):3385-91. PubMed ID: 2952716 [Abstract] [Full Text] [Related]
17. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor. Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L. Eur J Immunol; 1984 Dec 15; 14(12):1111-4. PubMed ID: 6240408 [Abstract] [Full Text] [Related]